Skip to content

Clinical trials

Terminated Multiple Myeloma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Terminated Country / region: France Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20052
20071
20082
20091
20112
20132
20142
20152
20163
20173
20182
20196
20205
20216
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Nantes University Hospital3
Amgen2
Assistance Publique - Hôpitaux de Paris2
Celgene2
GlaxoSmithKline2
Incyte Corporation2
Intergroupe Francophone du Myelome2
Oncopeptides AB2
Teva Branded Pharmaceutical Products R&D LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma47
Recurrence12
Lymphoma, Non-Hodgkin6
Leukemia, Myeloid, Acute5
Neoplasms5
Lymphoma4
Lymphoma, Large B-Cell, Diffuse4
Myelodysplastic Syndromes4
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.